Adolescence is a vulnerable developmental stage where significant changes occur in a youth's body, brain, environment and socialization, which may increase vulnerability to substance use, development of addiction, and psychiatric disorders. A co-occurrence of mental and behavioral disturbances with drug involvement in adolescence is common, as reflected in both a high risk for drug use in youth with mental illness and a high frequency of psychopathology among drug users. In this review we provide a broad and basic overview of some of the research evidence indicating a strong co-occurrence of drug use disorders (abuse and dependence) with externalizing and internalizing disorders, as well as a few other serious mental health conditions among adolescents. Increasing awareness and knowledge of the high probability of the co-occurrence of mental and behavioral disturbances with drug involvement informs the understanding of the etiology, course, and treatment of psychiatric problems among adolescents.
INTRODUCTION
Adolescence is a critical and vulnerable stage of development where significant changes occur in a youth's body, brain, environment and socialization, which may increase vulnerability to substance use, development of addiction and psychiatric disorders. The onset of substance use and mental and behavioral disturbances occurs for many during the adolescent years. Alcohol and nicotine obtained via the use of tobacco products are often the first and most frequently used substances among youth. Nicotine is fre quently used repeatedly on a daily basis and risky or excessive alcohol consumption is a problem for some. Cannabis is one of the most commonly used illegal drugs among youth in the United States and in other countries, but rates of nonmedical use of prescription (pain relievers, tranquilizers, stimulants, and depressants) and over-the-counter medications are also alarming. 1 For many, substance use transitions into developing problems associated with the use. The National Comorbidity Survey-Adolescent Supplement (NCS-A) conducted in the US between 2001 and 2004 estimates that approximately 36.6 percent of adolescent drug users meet criteria for substance abuse with or without dependence, 2 19.6 percent of smokers meet criteria for nicotine dependence, 3 and 27.5 percent of adolescent regular alcohol users developed alcohol abuse with or without dependence. 2 This same survey also estimates that nearly half of American youth meet lifetime criteria for at least one psychiatric disorder, with half of these associated with severe impairment. 4 Anxiety disorders were the most common condition (31.9%), followed by behavior disorders (19.1%), mood disorders (14.3%), and substance use disorders (SUDs) (11.4%).
Involvement with substances and mental and behavioral disturbances often co-occur among adolescents as reflected in both a high risk for substance use in youth with mental illness and a high frequency of psychopathology among substance users. One literature review of community studies estimated that 60 percent of youths involved with drugs had a comorbid psychiatric diagnosis. 5 In addition, the evidence from extensive study of comorbidity of SUDs and psychiatric disorders among adult samples highlights the importance of the need to understand the onset and progression of psychiatric and substance use problems and disorders among youth. [6] [7] [8] In this review we describe a framework often used for psychiatric disorders among adolescents, and then address some of the strengths and weaknesses of the research currently being used to study the comorbidity of SUDs and other psychiatric disorders. We then follow with a broad overview of some of the research evidence indicating a strong co-occurrence of SUDs with externalizing and internalizing disorders, as well as a few other serious mental health conditions among adolescents. After briefly describing some possible explanations for the comorbid condition, this review ends with recommendations for continued research to aid prevention and intervention efforts. The goal of this review is not to be exhaustive but to highlight the complexity of issues faced by researchers and the importance of the need to understand the phenomenon of comorbidity during the stage of life when these disorders emerge. Increasing awareness and knowledge of the high probability of the co-occurrence of mental and behavioral disturbances with substance use involvement can inform the understanding of the etiology, course, and treatment of psychiatric problems among adolescents.
DISCUSSION
One common theoretical framework for understanding psychiatric disorders among adolescents is the internalizing and externalizing model. 9 Internalization is the propensity to express distress inwards. Common internalizing disorders during adolescence include mood disorders such as major depressive disorder (MDD), dysthymia, and anxiety disorders including generalized anxiety disorder, separation anxiety disorder, phobias, and obsessive-compulsive disorder. Conversely, the propensity to express distress outwards is known as externalization. Disruptive behavior disorders such as attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, and conduct disorder (CD) are common externalizing disorders during adolescence. SUDs also fall under the category of disruptive behavior disorders, but for this review we address the comorbid condition co-occurring with one or more of other externalizing or internalizing disorders, thus known as a dual diagnosis. Factor analytic studies suggest distinctions between internalizing and externalizing disorders, [10] [11] [12] [13] however, evidence also suggests a high co-occurrence between as well as among these disorders in adolescence. [11] [12] [13] [14] It appears that psychopathology cannot be reduced to a simple structure. Patterns are influenced by gender, age, persistence, and the constellation of diagnoses included. 15, 16 These inconsistent patterns might be a key to understanding the associations and sequencing across disorders. 17 Since comorbidity implies that two disorders occur in the same individual simultaneously or sequentially, and that the interactions between the two disorders can affect the course and prognosis of either disorder, many studies have attempted to quantify and establish the temporal ordering of the comorbidity between SUDs and psychiatric disorders among youth. However, differences in the research design, samples, the assessment procedure and criteria used to identify 'cases', and other assessment issues (e.g., different informants, timeframe captured) often result in a wide variation of estimates and a limited depiction of the interplay and sequencing of symptoms and disorder development. Below we highlight some of the research issues faced by those studying comorbidity in adolescents and illustrate the diversity of research approaches taken by several selected studies.
Research designs and samples
The most common study design used in the field of comorbidity research is the cross-sectional study. Cross-sectional studies report a strong positive association between substance use and psychiatric disorders but rely heavily on accurate recall or use participants of different ages to estimate the probable inter-relatedness and temporality. Retrospective lifetime prevalence may under-estimate how common psychiatric disorders are. 18 Therefore, ideally to determine the comorbid relationship and order of onset of the disorders, researchers need to use prospective, longitudinal studies, in which adolescents are followed over long periods of time and monitored for the development of the disorders under investigation. A disadvantage to studying comorbidity using cohort studies is that they must be very large and have long follow-up time to accrue a sufficient numbers of cases.
The context of where the sample is drawn from and sample characteristics are important to consider in interpreting results and of course extremely important for generalization purposes. Policy and other environmental and social factors (e.g., taxation, minimum age laws, cultural morals and sanctions) can influence the availability and access to substances, thus patterns of specific substance use and SUD trajectories can vary among youth in different countries and even regions of a country. In addition, differences in the co-occurring rates and patterns of substance use and mental health problems have been found to vary by sex and age. [19] [20] [21] [22] Adolescents with comorbid disorders can be easily found in treatment facilities; an estimated 70 to 80 perent of youth seeking substance abuse treatment have one or more comorbid disorder. 23 Strengths of studies coming from clinical sites often include the rigorous assessments of not only a broader array of disorders, but also, of diagnoses that conform to the structure of the International Classification of Diseases (ICD) and Diagnostic and Statistical Manual of Mental Disorders (DSM) systems. They are especially useful when exploring comorbidity with less common specific disorders (e.g., Obsessive-Compulsive Disorder). However, clinical samples cannot provide unbiased rates or estimates of risk factors for comorbidity as many youth do not receive treatment or are not treated in clinical settings. Individuals seeking help often have more severe symptomology, and more impairment than those who do not seek treatment. To reduce the potential for selection biases, it is also important to evaluate the comorbid relationship in general population samples.
Many population based epidemiologic studies conducted in the US, including some prospective longitudinal studies, have utilized regional samples, and findings may not be generalizable to the general adolescent US population (e.g., Great Smokey Mountains Study of Youth; Oregon Adolescent Depression Project; Teen Health 2000). 19, [24] [25] [26] Indicators of mental health are included in several US national surveys of youth, [27] [28] [29] [30] [31] however the range of psychiatric disorders and identification of SUD, not only use, has been limited until recently. A main objective of the NCS-A was to provide empirical data of a wide range of psychiatric disorders from a nationally representative sample of US children and adolescents. 32 Researchers from other countries have also shed evidence on the cooccurrence of mental health issues and substance use among adolescents. Some examples include the Ontario Health Study which was a crosssectional community survey of children four to 16 years of age, 33 two famous New Zealand cohorts with long term follow-up: Christchurch Health and Development Study 34 and the Dunedin Multidisciplinary Health and Development Study, 35 and the Early Developmental Stages of Psychopathology Study that is following youth from Munich, Germany and surrounding areas over time and whose design features include linkage with a family supplement and neurobiological laboratory studies of highrisk subjects.
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Assessment issues
There are various approaches to assessing mental health conditions among youth; using instruments based on taxonomy or symptom scales. A psychiatric disorder diagnosed via the ICD or DSM schema requires specific criteria and signs of impairment. Issues can arise in how different studies apply and operationalize the criteria (not to mention that the DSM criteria have changed over time). For example, the NCS-A study has been criticized for using substance abuse symptoms to screen for dependence; as a result, it does not capture information on youth who meet criteria for dependence but never met criteria for abuse. 37 Also worth noting is that meeting disorder criteria does not necessarily imply functional impairment nor capture a severity threshold. On the other hand, clinically significant symptoms below the count necessary to warrant a diagnosis can be associated with functional impairment and are often the precursor of an emerging disorder and subthreshold diagnoses of substance use problems have been associated with psychiatric symptoms. 38, 39 Other common approaches used to screen for psychopathology among youth utilize lists of symptoms that often map onto DSM criteria. 40 Instead of classifying the presence or absence of a diagnosis, symptom scales are used to rank the probability of having emotional and behavioral problems that might require further evaluation, clinical services or preventive inter ventions.
Though only approximating a psychiatric diagnosis, they may be useful in detecting syndromes and subclinical symptoms. Studies using data obtained from one such tool, the Youth Self-Report (YSR) developed by Achenbach, 41 find emotional and/or behavioral problems to be associated with substance use. [42] [43] [44] Problem behaviors have also been associated with a rapid development of nicotine dependence among youth who recently initiated smoking 45 and with both single and multiple SUDs in early adulthood. 46 It takes time and resources to assess a variety of psychiatric and SUDs. The number and array of diagnoses one wishes to assess accurately creates challenges for the design and administration and adds to the respondent burden. Lay interviewers can administer structured instruments to assess psychiatric disorders but training is required. Assessing the various substances youth can become involved in, especially as they become older and have increased opportunities and access to illicit as well as non medical prescription type drugs, as well as mapping abuse and dependence criteria for each substance type can easily become daunting. Many studies, instead of describing SUD ascribed to specific substances, use an 'any' SUD approach. However, the choice of what substance one uses to define the SUD may influence comorbidity patterns as different substances have different effects (e.g., stimulant versus depressive) and the reasons for use may also vary between individual (e.g., seeking a high versus self medicating). Comorbid associations between SUDs and externalizing disorders are often the strongest and the association between marijuana dependence and other psychiatric disorders is often weaker than those with alcohol or other drugs. 19 Because of the low prevalence of many specific psychiatric disorders as well as SUDs resulting from certain substances, large sample sizes are needed for such specificity.
A controversial point in assessing substance use and psychiatric dis orders is whether it is sufficient to rely only on adolescent self-reports. A youth's knowledge of their own behavior and emotions makes them a potentially important contributor to the assessment process; however, comorbidity patterns among emotional and behavioral syndromes have been found to vary with the informant and there may be differential reporting by parents and youth by ethnic groups. 19, 47 Studies may use different informant sources such as parent reports only, youth report only, or a combination. Algorithm diagnoses cannot replace clinical judgment of the significance and impairment attributed to the diagnoses, but studies suggest that the general patterns of comorbidity are not affected by whether the data is put together by a clinician or by means of a computer algorithm scoring a structured interview. 21 Regardless of who the respondent is, another concern is how well does one distinguish and recall symptoms (potentially overlapping ones) over time.
Recall is also an extremely important limitation to establishing a greater understanding of the temporal sequencing, persistence and even reoccurrence of disorders. To avoid recall bias and have more immediate clinical relevance for treatment purposes, assessments tend to capture symptom experiences over a short time frame (i.e., a point prevalence of previous 30 days, 3 month or 12 month period). Surveys, on the other hand, often inquire about cumulative lifetime experiences. Retrospective recall bias may be less of an issue among adolescents because they are reflecting back upon fewer accumulated years of life than adults, but special probes as those used in the NCS-A that have been found to help increase recall among adults might still be useful in helping the youth to recall their experiences more reliably. 48 Another cautionary note relates to a limitation of the term comorbidity, as it does not distinguish between a multitude of different temporal relationships among disorders. Angold and colleagues suggested differentiating concurrent from successive comorbidity.
14 In concurrent comorbidity, even if the time of onset and offset are not coterminous, the disorders must have at some point in time been present concurrently (or if not in time in phenomenology). This type of comorbidity is often captured in studies that have assessed point (current) prevalence. On the other hand, studies assessing lifetime prevalence may not determine if the disorders ever occurred simultaneously, suggesting that the term successive comorbidity may be more appropriate. Thus, when comparing results across studies comorbidity rates can be very different, probably because lifetime comorbidity although capturing a longer time period relays heavily on recall. However, lifetime prevalence based on retrospective age-of-onset reports from cross sectional studies may be used to help capture the development of comorbidity by distinguishing the onset versus the per sistence of the disorders. 17 An even stronger design would be to study the temporal sequencing of lifetime and current disorders in a longitudinal cohort of adolescents as with the Early Developmental Stages of Psycho pathology Study. 49 Finally, caution must also be taken not to artificially elevate the rates for psychiatric disorders because of a tendency to establish a diagnosis before some of the psychiatric symptomatology secondary to the substance use abates. A diagnosis of a substance-induced mental disorder may be averted by observing the adolescent for a minimum of four weeks after discontinuing drug use. For example, cocaine-induced states need to be clearly differentiated from schizophrenia, mood disorders, and anxiety disorders. Ruling this out may be difficult for adolescents to establish on their own when they are self reporting symptoms on a survey with fewer probes than what might occur in a clinical assessment as they may not recognize the connection.
As seen from the brief review of research issues above, the complexity of the subject matter increases the need for sophistication in how we study and understand it. It does not necessarily mean the literature is flawed, but caution should be taken when making inferences and generalizations based upon findings from different studies. Instead of relying on deductions about the onset of comorbidity obtained from adult studies fraught with recall biases, we need to obtain a clearer picture of what is happening during the developmental stages of youth as symptoms and behaviors onset to determine trajectories of persistence and severity. Evidence already suggests there are specific features of substance use and the psychiatric condition that merit attention and detailed prospective monitoring. Therefore, future research should, whenever possible, focus on longitudinal study designs that start collecting data in early childhood of representative samples of youth in order to disentangle premorbid pathways that lead to comorbid SUD and psychiatric disorders.
Research Evidence
Next our review highlights some of the evidence on the magnitude and the kinds of co-occurring psychiatric and SUDs reported in some selected clinical samples as well as population-based studies of adolescents. A search of the PubMed, PsychInfo and Scopus databases identified several clinical and general population studies published in the past 15 years that specifically included adolescent samples with comorbid substance use and psychiatric disorders. Search terms included specific internalizing and externalizing disorders (e.g., ADHD, anxiety, depression) and SUD (including substance abuse, substance dependence, drug abuse, drug dependence, alcohol abuse, alcohol dependence). A preference was given for studies using diagnoses obtained via structured interviews and epidemiologic studies that used probability/representative sampling. In addition, because our main focus was on SUDs, studies focusing on comorbid substance use/drug use and psychiatric disorders were excluded. We observed a tendency for some research teams to strictly focus (or at least only publish) on either externalizing or internalizing disorders, not always both, as well as often limiting the assay of substance disorder to the more commonly used substances (e.g., alcohol and cannabis).
Globally, national estimates of the overall occurrence of comorbidity are generally lacking as not all studies of adolescent samples focus on one of the comorbid disorders being SUDs per se, nor are structured diagnostic assessments routinely used to assess both the substance use and mental health status. In the US, the Oregon Adolescent Depression Project found that twice as many adolescents with a SUD also had a psychiatric disorder (66.2%) compared to those with a psychiatric disorder who had a SUD (31.3%). 50 More recently, the NCS-A study reported 40 percent of adolescents with one class of disorder also met criteria for another class of lifetime disorder. 4 Hopefully, future publications of the NCS-A will provide greater distinction of specific comorbid patterns as the 40 percent is likely an over estimation of the kind of comorbidity we are focusing on (substance use and psychiatric disorders), as comorbidity between other internalizing and externalizing disorders where SUDs are not present also occurs. In the meantime, findings from a study of a probability sample of youth enrolled in a health maintenance organization provide some interesting insights. The patterns of comorbidity suggest that the comorbid relationship between a SUD and psychiatric disorder may vary by the type of substance (e.g., less with marijuana), by the type of SUD (e.g., less with abuse versus dependence), and by the type of psychiatric disorder (e.g., strongest for behavioral disorders). 19 Some of these patterns have also been seen in adult data and may also extend to subthreshold disorders as well. 50, 51 The type of psychiatric paychopathology most commonly diagnosed in adolescents with SUDs are the externalizing disorders. 53 Clinical studies document a high degree of co-occurrence of ADHD and CD among adolescent samples with SUDs (Table 1 ). Since many of the samples were derived from treatment programs a wide array of substances were included under the any SUD classification as youth having problems with one substance type often are using other substances as well. The sample variation in age, sex and other factors, such as racial mix, inner city versus rural setting, or type of program or center in which the research was performed result in a wide range of comorbid rates. However, these clinical studies indicate the importance of exploring subgroup variation. For example, gender differences were often greater among those with comorbid ADHD and alcohol disorder than with comorbid CD and alcohol disorder. Additionally, race/ethnicity differences were observed among youth with SUD, indicating that Whites, Hispanics, individuals of mixed race, and individuals endorsing "other" race exhibited greater rates of either ADHD or CD than did African Americans or American Indian/Alaskan Natives with SUD.
Congruent with findings from clinical studies, evidence from epidemiologic studies of various designs indicate the comorbidity between externalizing disorders and SUDs in adolescents exists in the general population as well (Table 2 ). These studies also show that in addition to ADHD and CD, oppositional defiant disorder (ODD) commonly co-occurs with SUD in the adolescent population. 22, [54] [55] [56] [57] [58] Many of the SUD disorders are substance specific or the any SUD is based on the more commonly used substances at younger ages: nicotine, alcohol and cannabis. Several of the epidemiologic studies include information obtained from other informants when making diagnostic classifications. Evidence from several of the longitudinal studies analyzing the co-occurrence prospectively find that the onset of externalizing psychopathology tends to precede the development of SUDs. 34, 59, 60 In addition to descriptions of categorical classifications of externalizing psychopathology, a body of literature exists that describes how specific components or symptoms and personality traits are associated with substance use and SUDs in adolescence. In particular, many studies find that aggressive behavior, a component of CD, and violence accompany and often precede adolescent substance use and SUD. [61] [62] [63] [64] Additionally, impulsivity, one of the components of ADHD, is often associated with initiation of alcohol use in adolescence, 65 while hyperactivity in childhood is associated with a greater likelihood of being arrested in young adulthood for charges stemming from illegal drug possession, use, and sale. 66 Furthermore, it is possible that reciprocal relationships exist between psychopathological symptoms and substance use behaviors, as certain drugs, such as alcohol, anabolic steroids, benzodiazepines, and cocaine can escalate the development of aggression and violent behavior.
Evidence of a high prevalence of a co-occurrence between internalizing disorders and SUDs is also shown in both clinical and epidemiologic studies. 53, 67 A review found evidence that comorbidity rates are higher in samples of adolescents where SUD appeared first than among youth where internalizing disorders preceded the onset of other disorders. 67 Table 3 provides some examples of clinical-based research where high rates of internalizing disorders, particularly MDD, are often found among adolescent samples who are in treatment for SUDs. On the other hand, adolescents in treatment for psychiatric disorders also have comorbid SUDs. 68 Modest rates of anxiety disorders, especially posttraumatic stress disorder, are also often found among youths with SUDs, ranging from six percent to 38 percent. 69, 70 Studies also find comorbidity between SUD in adolescence and bipolar disorder. 71, 72 As seen in the clinical studies of externalizing disorders, the substances included in the disorder category vary across studies, as do sample characteristics. Gender differences were noted by a few of the studies where females tend to have higher rates of comorbidity between SUDs and internalizing disorders than males.
Numerous epidemiologic studies find mood and anxiety disorders strongly associated with SUDs in more general population samples of adolescence (Table 4 ). In many of these studies the SUD disorders are substance specific but in some studies the SUD includes other illegal drugs that are sometimes not specified as to what particular type of substances were included. A few of the studies included information obtained from a caregiver in addition to reports by the adolescent when deriving disorder classifications. Many of the longitudinal studies indicate that the onset of internalizing disorders precedes the onset of SUDs, 22, 73, 74 while others argue for reciprocal pathways between SUDs and internalizing disorders. 58, 75 Late adolescence and early adulthood are also peak periods for the onset of other serious mental illnesses and abnormal/maladaptive behavior. Excessive use of drugs and/or alcohol are very common among youth with schizophrenia. 76, 77 Cannabis, amphetamine, cocaine, and to a lesser extent alcohol, are associated with psychosis. [78] [79] [80] Eating disorders are frequently associated with substance use and are common among adolescents having SUDs. 81, 82 It has been speculated that young women with anorexia may initiate drug use in an effort to lose weight and that those with bulimia nervosa may be turning to substances to dampen purging symptoms and behaviors. 83 SUDs and sleep disorders also often co-occur and have a significant negative effect upon normal development and are associated with deleterious effects on mood, attention, and behavior. 84, 85 In addition, there is accumulating evidence from clinical and epidemiological studies on the link between drug use and suicide among adolescents, 86, 87 with comorbidity increasing the risk for suicidal behaviors. 88 Alcohol abuse and dependence, cigarette smoking and cannabis use have been found to be associated with suicide attempts among adolescents. 89, 90 The intoxicating effects of drug use might lead to impairments in judgment or changes in mood which then increase risk for suicidal ideation and attempt 91 and alcohol-specific effects such as disinhibition and emotional or behavioral problems (dysphoria, impulsivity, and aggression) have been implicated in suicidal behaviors. 92 While a goal of many studies is to make available evidence on the temporal order and sequencing of onset of substance use and disorder and the various psychiatric disorders, publications often do not include descriptives of the ages of onset. Table 5 summarizes the age of onset for major disorder groups described by several adolescent studies. Whereas sequencing can vary on an individual basis, the evidence appears to indicate that on average anxiety and behavior disorders precede SUDs, while there is less time differential between mood disorders and SUDs. On average, psychiatric disorders also precede nicotine dependence by at least two years. 22, 93, 94 Paths to comorbidity have been noted to differ by sex. 22 In addition, sensitivity to distinct trajectories may be warranted as externalizing disorders typically have onset in childhood or adolescence and then may persist into adulthood or decrease with age, while the onset of internalizing disorders occurs over the life course with their cumulative prevalence generally increasing with age. In summary, numerous studies establish a comorbid association, but population estimates of how many, the when, and which youth are affected are scarce. In addition, more childhood and adolescent studies on the sequencing of the disorders, as well as how and the conditions under which the behaviors and mood conditions develop, are needed to obtain a greater understanding of the trajectories that will inform opportunities for prevention and intervention.
Possible explanations
There are several possible explanations of why there is a connection between substance use and mental illness. Empirical research supports the existence of risk factors from multiple domains hypothesized in the social development model, 95 such as one's individual attributes, attitudes and opportunities, family or household structure and recent life events. Problem behavior syndrome and an array of complementary conceptual models link externalizing type behaviors such as aggression, rule breaking, and other socially maladaptive behaviors with tobacco use and drug-taking.
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The co-occurrence adds a complexity to understanding the intricate relationship and etiology. Understanding the sequencing behind the high prevalence of co-occurrences of drug abuse and psychopathology is not simple; one cannot assume just because one appeared first that it caused the other. Often emotional and behavior problems are found to precede drug use. [101] [102] [103] Externalizing behaviors have been associated with the progression of drug use, whether progression in stage of use within a particular drug 104 or becoming involved with other drugs, such as marijuana and inhalants. 105, 106 This suggests some youth may be using drugs to self medicate. However, evidence that drug use precedes mental health outcomes also exists. Substance use and drug-related problems have both been shown to relate to disruptive behavior diagnoses. 107, 108 Mood changes are a common feature during withdrawal from several drugs of abuse. 109 The shared liabilities of drug use disorders and other mental illnesses may also be due to genetic as well as environmental influences. [110] [111] [112] [113] [114] Family-genetic studies provide evidence of linkage between depression and drug abuse and substance disorders. 115, 116 Alterations in reward and motivational processes might play a central role in the manifestation of core symptoms of both drug and psychiatric disorders. 117, 119 Many theories and models of comorbidity have been postulated. These models often include multiple domains and highlight that there may be several different mechanisms and routes leading to comorbidity. New collection efforts should also seek to incorporate genetic as well as environmental influences that may impact the onset of comorbidity and allow study of the complex genetic interactions between a wide array of environmental factors.
RECOMMENDATIONS
The presence of high co-occurrence of externalizing and internalizing disorders among youth abusing drugs and alcohol deserves attention to detect and provide appropriate treatment and referral for these problems as the burden of this comorbidity is significant. Previous reviews of adolescent out comes found strong evidence that this comorbid combination was associated with truancy, rebelliousness, academic problems, and school drop out. 14, 24 In addition, other studies point to the added economic and psycho social burden of having comorbid disorders, and less overall well being, including higher levels of psychopathology, suicidal ideation, and greater functional impairment. 19, [120] [121] [122] Further substantiating the importance of the need for prevention and early intervention among the adolescent years is the continued impact of comorbidity on young adult roles and behaviors. Comorbidity has been found to be associated with arrests, continued drug use, and reductions in work productivity 49, 123 and among HIV-infected individuals with decreased odds of highly active antiretroviral therapy (HAART) utilization and viral suppression. 124 Having both psychiatric and SUDs increases impairment and results in poorer prognosis.
Complications of co-occurring disorders on treatment outcome are also well-documented, as the complexity of problems may impair an adolescent's ability to effectively engage in treatment 125 and can increase the rate and rapidity of relapse. 126 Findings have shown that many substance abuse treatment clients with less serious psychiatric disorders do well with traditional substance abuse treatment methods, while those with more serious psychiatric disorders need intervention modifications and additions to enhance treatment effectiveness. 127 The US Center for Substance Abuse Treatment has published best-practice guidelines for treating and recognizing the high overlap of psychiatric disorders among both substance abuse and mental health treatment clients. 127 Pharmacological advances over the past few decades have produced more effective psychiatric medications with fewer side effects that allow individuals with serious and persistent psychopathology to participate in treatment instead of being institutionalized, thus increasing the demand for integrated treatment. However, the development of integrated treatment requires both an understanding of psychopathology and addiction and the means to integrate and modify traditional treatment approaches in both the mental health and addiction treatment fields. 128 Several strategies found to have promise for dual treatment of substance use and psychiatric disorders include: Motivational Interviewing, Contingency Management, CognitiveBehavioral Therapy, Relapse Prevention, Assertive Community Treatment, and Intensive Case Management. 127 Randomized control trials are beginning to provide evidence that pharmacologic and psychological interventions are effective. 129, 130 Research is providing information on client factors as well as treatment facility facilitators and barriers to strengthen the integrated dual disorder treatment model. [131] [132] [133] [134] Continuity of care is necessary to guide individuals between service systems and continuing support and aid obtained via self help approaches is needed in the community for long term success.
Understanding the complexity between psychopathology and drug abuse, including the sequencing between both, would help guide us to knowing what to target and when to intervene. 135 For example, for a young adolescent with CD or ADHD who began using drugs at an early age, an intervention program could have an effect on future drug disorders by reducing current drug use, or by ameliorating current disruptive problem behaviors, or both. A program that targets only the drug use might have little effect on youth at risk for future SUDs because of their history of behavioral problems, while a program targeting only the behavioral problems might have little effect on youth put at risk because of their early drug use. An example of a universal behavioral intervention provided at a very young age, as children enter the educational system, that has been tested in community randomized control trials has shown that non-pharma ceutical approaches of prevention may be possible. Teachers use classroom behavior management strategies to socialize children to the student role and reduce aggressive and disruptive behaviors. This strategy, the Good Behavior Game, 136 has been found to lower the rate of school-based service use (being placed in a special school or special classroom for problems with behavior, feelings, or drug or alcohol; receiving special help in the regular classroom; and receiving other counseling or therapy in school) 137 and reduce drug and alcohol abuse/dependence disorders, regular smoking, and antisocial personality disorder among males. 138 Behavior-influence procedures offer a unique opportunity for the prevention of substance use and psychiatric disorders at a public-health level. 139 Studies pursuing influences and the identification of the mechanisms behind the high co-occurrence of SUDs and psychiatric disorders among youth are needed. We must continue to disentangle the complex temporal relationship. It is important to optimize the research design and methods in order to collect and analyze data that can make further contributions in depicting the interplay and sequencing of symptoms and disorder development.
SUMMARY
There is strong evidence from clinical and population based studies that SUDs co-occur with externalizing and internalizing disorders, as well as other serious mental health conditions among adolescents. The ramifications and consequences of having comorbid disorders, as opposed to unitary conditions of drug abuse separate from emotional and other behavioral problems, are complex. Traditional treatment and prevention approaches for adolescent well being require modifications to broaden their assessments to detect comorbid conditions. Not only should drug using adolescents be screened for psychopatholgy, but visa versa. In addition the identification and evaluation of comorbid disorders should not be limited to concurrency defined only by one point in time but take into consideration the history of drug involvement and mental health over the entire developmental lifespan. It is imperative that researchers continue to develop a better understanding of the co-occurrence (pre existing or consequential) of substance use and mental illness among youth in hopes of forestalling significant morbidity and mortality, such as disfunctionality or suicide. Dr. Silvia Martins, MD, PhD, is a faculty member of the Psych-Neuro cluster of the Department of Epidemiology, Columbia University Mailman School of Public Health. She has been the Principle Investigator and Co-Investigator on several NIH research grants. She is currently the academic coordinator of the NIDA T32 Substance Use Disorders Training Program in the department. Her research focuses on environmental and individual factors associated with substance use and substance use disorders (with a special focus on nonmedical use of prescription drugs), psychiatric disorders and gambling/problem gambling both with US and inter national data.
